Non‐Epidemic Kaposi Sarcoma Refractory to Laser Therapy in an HIV‐Negative Man Who Has Sex With Men (MSM)

ABSTRACT Kaposi sarcoma (KS) is a vascular neoplasm associated with human herpesvirus 8 (HHV‐8), typically affecting immunocompromised individuals. However, emerging reports describe cases in HIV‐negative men who have sex with men (MSM), constituting a proposed non‐epidemic variant. We report the case of a 50‐year‐old immunocompetent MSM who presented with violaceous papules on the right foot, histologically confirmed as KS. Extensive workup ruled out systemic involvement and HIV infection. Initial treatment with CO₂ laser achieved partial response, but lesion recurrence prompted additional laser interventions, including pulsed dye laser (PDL), 532‐nm KTP laser and combined PDL/Nd:YAG laser therapy. Despite multiple sessions and varied parameters, no significant clinical improvement was observed, and disease progression continued with new lesions affecting contralateral and distant sites. Ultimately, radiotherapy was administered, achieving complete remission. This case illustrates the diagnostic and therapeutic challenges of non‐epidemic KS. Although laser therapies are increasingly used for localized KS, especially for cosmetic and symptomatic relief, their efficacy remains variable. Our findings align with prior reports demonstrating inconsistent outcomes and high recurrence rates following laser monotherapy. This case underscores the necessity of individualized treatment planning and highlights radiotherapy as an effective option for refractory disease. Furthermore, it emphasizes the need for heightened clinical awareness of KS in HIV‐negative MSM, even in the absence of immunosuppression. Continued investigation is warranted to define optimal treatment strategies for this KS variant and to clarify the role of laser modalities in long‐term disease control.

Authors

Institutions

Publication Details

Journal
JEADV Clinical Practice
Published
2025-10-26
DOI
https://doi.org/10.1002/jvc2.70183
Primary Topic
Viral-associated cancers and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Non‐Epidemic Kaposi Sarcoma Refractory to Laser Therapy in an HIV‐Negative Man Who Has Sex With Men (MSM)

C. J. Alejos Grau, F. Lista, Jesús del Pozo Losada, Machado Lopes et al.
JEADV Clinical Practice
Viral-associated cancers and disorders
article

Non‐Epidemic Kaposi Sarcoma Refractory to Laser Therapy in an HIV‐Negative Man Who Has Sex With Men (MSM)

C. J. Alejos Grau, F. Lista, Jesús del Pozo Losada, Machado Lopes, Inês Loureiro
article en

Abstract

ABSTRACT Kaposi sarcoma (KS) is a vascular neoplasm associated with human herpesvirus 8 (HHV‐8), typically affecting immunocompromised individuals. However, emerging reports describe cases in HIV‐negative men who have sex with men (MSM), constituting a proposed non‐epidemic variant. We report the case of a 50‐year‐old immunocompetent MSM who presented with violaceous papules on the right foot, histologically confirmed as KS. Extensive workup ruled out systemic involvement and HIV infection. Initial treatment with CO₂ laser achieved partial response, but lesion recurrence prompted additional laser interventions, including pulsed dye laser (PDL), 532‐nm KTP laser and combined PDL/Nd:YAG laser therapy. Despite multiple sessions and varied parameters, no significant clinical improvement was observed, and disease progression continued with new lesions affecting contralateral and distant sites. Ultimately, radiotherapy was administered, achieving complete remission. This case illustrates the diagnostic and therapeutic challenges of non‐epidemic KS. Although laser therapies are increasingly used for localized KS, especially for cosmetic and symptomatic relief, their efficacy remains variable. Our findings align with prior reports demonstrating inconsistent outcomes and high recurrence rates following laser monotherapy. This case underscores the necessity of individualized treatment planning and highlights radiotherapy as an effective option for refractory disease. Furthermore, it emphasizes the need for heightened clinical awareness of KS in HIV‐negative MSM, even in the absence of immunosuppression. Continued investigation is warranted to define optimal treatment strategies for this KS variant and to clarify the role of laser modalities in long‐term disease control.

JEADV Clinical PracticeVol. 5(1)
Complejo Hospitalario de Salamanca (ES), Hospital de Sabadell (ES), Complexo Hospitalario Universitario A Coruña (ES)
Openalex Percentile: Top 58%
Viral-associated cancers and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.